Gilead Sciences, Inc. Appoints Two New Members to Health Policy Advisory Board

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today the appointments of Lord Paul Boateng, LLB, member of the United Kingdom House of Lords, and Hannah Kettler, PhD, senior health program officer and economist at the Bill & Melinda Gates Foundation, to the Gilead Health Policy Advisory Board. The advisory board - comprised of leading experts in their fields - provides external perspective and advice, helping the company shape programs and policies to deliver medications to patients affected by HIV/AIDS, viral hepatitis and other life-threatening diseases around the world.
MORE ON THIS TOPIC